Home | Welcome to Contract Pharma   
Last Updated Thursday, December 18 2014

Print

Horizon appoints CBO



By Kristin Brooks



Published March 5, 2014
Related Searches: pharma companies Pharma
Robert F. Carey has been appointed executive vice president and chief business officer at Horizon Pharma, Inc. Mr. Carey brings extensive healthcare investment banking experience having assisted biotech and specialty pharma companies raise more than $10 billion in initial public offerings, follow-on offerings, debt offerings and private placements. He has also served as a financial advisor on mergers, acquisitions and strategic alliances.
 
Mr. Carey joins the company from JMP Securities LLC, where spent more than 11 years as managing director and head of the life sciences investment banking group. Prior to JMP, Mr. Carey was a managing director in the healthcare groups at Dresdner Kleinwort Wasserstein and Vector Securities, and held roles at Red Hen Bread, InStadium, Shearson Lehman Hutton and Ernst & Whinney.
 
"Bob's tremendous industry and deal-making experience will be invaluable to us as we look to expand our business through acquisitions of products and companies," said Timothy P. Walbert, chairman, president and chief executive officer, Horizon Pharma. "With our focus on acquiring additional innovative medicines or companies that complement our products and leverage our commercial infrastructure, Bob is a key addition to our executive team."


blog comments powered by Disqus

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On